From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugsRebecca L. McIntyre, Georges E. Janssens|EMBO Molecular Medicine|2019Cited by 118
Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical modelsLuis Filipe Costa‐Machado, Pablo J. Fernández-Marcos, Álvaro Ballesteros-Gonzalez et al.|Nature Communications|2023Cited by 39